REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/25/2026
Back to search
Official data from USPTO
TESSARA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
05/26/2026
Trademark type
Word
Nice classes
42
Filing date
03/17/2020
Registration date
05/25/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/25/2021
Last transaction
05/26/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
MCCAULEY, BRENDAN D
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Tessara Therapeutics Pty Ltd
Representatives
Charles G. Zug Nelson Mullins Riley & Scarborough LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research and development; biotechnology research and development; analysis of human tissues for medical research; biological sample analysis for scientific and medical research purposes; product development of diagnostic apparatuses; pharmaceutical drug development services; pharmaceutical research and development; product development consultancy relating to research and development in the field of therapeutics; medicalscientificnew product research in the field of gene therapy; providing new products testingquality testing and safety testing in the fields of scientific and medical research relating to research and development of medicinesdrug discoverypharmaceutical drug development and drug screening for scientific research purposes and consultancy related thereto; scientific research relating to the isolation and cultivation of human tissues and cells
Publications
History of USPTO decisions and trademark events.
26 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/10/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/04/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/16/2021
FIMP
FINAL DISPOSITION PROCESSED
09/16/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/25/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/25/2021
GPNX
NOTIFICATION PROCESSED BY IB
03/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/09/2021
PUBO
PUBLISHED FOR OPPOSITION
03/09/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/24/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/24/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/01/2021
RFNT
REFUSAL PROCESSED BY IB
09/27/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/05/2020
RFRR
REFUSAL PROCESSED BY MPU
08/26/2020
MAFR
APPLICATION FILING RECEIPT MAILED
07/25/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/22/2020
CNRT
NON-FINAL ACTION WRITTEN
07/21/2020
DOCK
ASSIGNED TO EXAMINER
07/21/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/21/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/16/2020
Continuous trademark protection
Get notified about every new filing that threatens TESSARA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.